SureNano Science

SureNano Science EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of SureNano Science (SURE.CN) as of Oct 21, 2026 is -10.37 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -445.89 % — a change of -97.67% (higher).

EBIT/Assets

-10.37 %

YoY

-97.67%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of SureNano Science is 2026 -10.37 % . Operating Income to Assets Ratio (EBIT/Assets) of SureNano Science was 2025 -445.89 % . It decreases by -97.67% higher compared to the previous year.

The SureNano Science EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2021
-8.44 CAD
Jan 1, 2022
-162.83 CAD
Jan 1, 2023
-122.61 CAD
Jan 1, 2024
-182.80 CAD
Jan 1, 2025
-445.89 CAD
Jan 1, 2026
-10.37 CAD
The SureNano Science EBIT/Assets history
YEAREBIT/AssetsYoY
-10.37 %-97.67%
-445.89 %+143.92%
-182.80 %+49.09%
-122.61 %-24.70%
-162.83 %+1,829.26%
-8.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SureNano Science Stock analysis

What does SureNano Science do? SureNano Science Ltd. generates revenue through the sale and commercialization of the SureNano surfactant, a ready-to-mix food grade compound designed for high performance nano-emulsions. The company holds distribution licenses for Canada, Oklahoma, and Colorado, targeting food and beverage manufacturers seeking to enhance product stability, bioavailability, and taste. Its primary customers are food and beverage producers requiring advanced emulsion solutions for their products. The SureNano surfactant is positioned as a specialized ingredient for creating homogeneous and stable nano-emulsions, appealing to manufacturers aiming to improve product clarity and taste without compromising quality. Distribution rights within specific regions allow the company to serve a focused market segment, leveraging exclusive licensing agreements to secure sales in key territories. Revenue streams are derived from direct sales of the SureNano surfactant to food and beverage companies operating within the licensed regions. The product's unique formulation supports applications in high-performance food and beverage products, driving demand among manufacturers focused on innovation and quality enhancement. SureNano Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SureNano Science stock

Operating Income to Assets Ratio (EBIT/Assets) of SureNano Science is -10.37 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of SureNano Science changed from -445.89 % to -10.37 %, representing a -97.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) SureNano Science since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s SureNano Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — SureNano Science

All Key Metrics — SureNano Science